Light ’em if you got ’em—plenty of Hoosiers on Medicaid doing just that
A new report by the Centers for Disease Control and Prevention is pushing states with high Medicaid smoking rates to do more to encourage enrollees to quit and live longer.
Health Care & Life Sciences
Articles
Lilly partners with AstraZeneca on another Alzheimer’s treatment
The Indianapolis-based company, which last month struck out in a late-stage clinical trial for a potential Alzheimer’s drug called solanezumab, announced Friday a collaboration with AstraZeneca to develop another possible treatment for the mind-robbing disease.
State official barred from taking job with senior-living company
An Indiana state official in charge of regulatory oversight of nursing homes and residential care facilities has been barred from taking a job at a private company that runs senior living communities over ethics concerns.
Health insurers willing to give up key Obamacare provision
U.S. health insurers signaled Tuesday that they’re willing to give up a cornerstone provision of Obamacare that requires all Americans to have insurance.
After rough November, some good news for Lilly
The FDA says the Indianapolis-based drugmaker and its partner can make an important label claim on its new diabetes drug—a move analysts say could give sales a big boost.
Lilly competitor to cap price increases as drug costs face more scrutiny
With drug companies under fire, the world’s largest insulin maker plans to limit price increases and introducing a model that ties the cost of medicines to the results they deliver.
Lilly to lay off hundreds after failure of Alzheimer’s drug
Eli Lilly and Co. plans to lay off hundreds of U.S. sales representatives in coming months, following the disappointing failure of an experimental drug for Alzheimer’s disease announced last week.
At Eli Lilly, tears, heartbreak and renewed determination
Eli Lilly and Co. employees knew the Alzheimer's treatment solanezumab was not a sure bet. But that didn’t make the pain any less acute after the company announced the drug had failed to demonstrate effectiveness during a 2,100-patient Phase 3 clinical trial.
Anthem’s Cigna takeover could draw $3B Blue Cross fine, exec testifies
Twenty-three percent of Cigna’s domestic revenue would need to be rebranded to comply with rules of the Blue Cross Blue Shield association, said Anthem executive Steve Schlegel under questioning Wednesday by a Justice Department lawyer.
Anthem-Cigna CEOs’ deep clash exposed in unsealed testimony
The rift between merging health insurance companies Cigna Corp. and Anthem Inc. came further into public view Tuesday as transcripts of testimony from both chief executives were unsealed during a U.S. antitrust trial
Anthem experts testify Cigna merger won’t hurt competition
Anthem Inc. fired back against U.S. claims that the health insurer’s planned $48 billion takeover of rival Cigna Corp. will undermine competition.
Sens. Sanders, Warren call massive research bill gift to drug firms
The $6.3 billion bill would let the Food and Drug Administration approve drugs and medical devices more quickly and bolster federal mental health programs.
Trump picks Pence ally Verma for cabinet position
President-elect Donald Trump on Tuesday said he’ll nominate Seema Verma, founder of Indianapolis-based SVC Inc. and architect of the Healthy Indiana Plan, as his pick for administrator of the Centers for Medicare and Medicaid Services.
Purdue keeping tons of lab gloves from landfills
What happens to a laboratory glove after a doctor, nurse or lab worker snaps it off and throws it in the bin? Usually, it goes to a landfill, but Purdue and partners are working to change that.
Old Greenwood city hall acquired, lands tenant
Cornerstone Autism Center plans to hire about 30 employees in the next year in the 96-year-old Polk Building, which is undergoing a major rehab by its new owner.
Anthem, Cigna to begin court fight to save $48 billion merger
Anthem Inc.’s proposed merger with Cigna Corp. would reduce health-care competition and raise costs for consumers, U.S. antitrust lawyers will argue Monday when the government goes to court to try to block the transaction.
Lilly CEO: Find overlap between corporate mission, philanthropy
John Lechleiter told local leaders Friday morning that while community engagement might not immediately impact the bottom line, it can be beneficial to a company’s ongoing mission.
Hospital food alert: Why Methodist is upgrading its massive kitchen
Hospitals are under pressure to serve healthier fare. Patients, health groups and news organizations are turning up the fire.
Patients rush to surgery before insurance deductibles reset
For patients, the difference between getting an operation now or in January could amount to thousands of dollars out of pocket.
From banker to caregiver, Steve Schenck has memories to cherish
Schenck's wife, Becky, was diagnosed with terminal brain cancer in 2006 and told she had only 12 to 15 months to live. She defied the odds and lived 10 years beyond her prognosis—time together Steve cherishes and wouldn’t trade for anything.